Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Lonza launches new website to support bioresearch, drug discovery scientists

Lonza Bioscience is inviting visitors to explore its new dedicated website: bioscience.lonza.com. Filled with detailed application and product information, the website has been designed to support the work of scientists across the bioresearch, drug discovery and pharmaceutical manufacturing fields.

From Lonza 3 Jul 2018

New research project could reduce chance of infection after orthopedic surgery

South Australian researchers are embarking on a $20 million medical and manufacturing research project which could reduce the chance of infection after orthopaedic surgery, thanks to a little help from the humble dragonfly.

2 Jul 2018

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.

30 Jun 2018

City of Hope receives $3.7 million from CIRM to develop phase 1 glioblastoma trial

The California Institute for Regenerative Medicine board has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy.

30 Jun 2018

Study provides insight into development of autism in the human brain

In a study published in Stem Cell Reports, a McGill team of scientists led by Dr. Carl Ernst, researcher at the Douglas Hospital Research Centre, revealed a molecular mechanism that may play a role in the development of autism.

27 Jun 2018

Uson announces reliable, highly accurate, multi-application leak tester

Uson announces the new SprintmD leak tester that is specifically designed to accommodate complex test procedures, multifunctional testing, and part-integrity testing that are required to comply with increasingly stringent regulations.

26 Jun 2018

Using machine learning to make proactive industrial maintenance more effective

Over the past five years, the industrial sector has begun to see the value in digitalization and has invested more in adopting it. With this has come a cultural shift from reactive equipment maintenance to proactive maintenance that pre-empts problems.

From Novotek AB 22 Jun 2018

Minakem's new high-class production facility extends capacity to develop and manufacture HPAPI compounds

Minakem, the CDMO division of Minafin, specialized in custom development and manufacturing of building blocks, GMP intermediates and Active Pharmaceutical Ingredients, today announces it is in the final qualification run to open a new closed-controlled environment high containment production facility in August.

22 Jun 2018

Investigating the Unique Nanomechanical Properties of Tooth Enamel

My background is in tribology, which is the science of the interactions between surfaces in relative motion. This involves looking at behaviour, such as friction, wear and lubrication, and the relationships between them.

From Bruker Nano Surfaces and Metrology 22 Jun 2018

CellGenix completes first phase of facility expansion to meet rising demands for GMP cell culture reagents

CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters’ expansion as more customers approach late-stage clinical development and commercialization.

22 Jun 2018

FDA expands approval of novel diabetes management device to include younger pediatric patients

The U.S. Food and Drug Administration today expanded the approval of the MiniMed 670G hybrid closed looped system, a diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the user, to include individuals aged 7 to 13 with type 1 diabetes.

21 Jun 2018

New collaboration integrates Intabio's Blaze solution with Bruker's mass spectrometers

Intabio, Inc., announced today that it has entered into a collaboration with Bruker to accelerate integration of Intabio's Blaze™ solution with Bruker's high resolution mass spectrometers.

From Bruker Life Sciences Mass Spectrometry 14 Jun 2018

How America got hooked on a deadly drug

Purdue Pharma left almost nothing to chance in its whirlwind marketing of its new painkiller OxyContin.

13 Jun 2018

Vetter's new campaign aims to examine applicability of digital trends to injection systems

How can digital trends be used purposefully in regards to the application of injection systems? That is the key question being addressed by Vetter’s Open Innovation Challenge.

13 Jun 2018

InDevR releases first reagent kit for assessing neuraminidase in influenza vaccines

InDevR Inc. announced product release of the first ever commercial reagent kit designed explicitly for assessment of neuraminidase in influenza vaccines.

12 Jun 2018

Cureworks collaborative aims to accelerate development of immunotherapies for pediatric cancer

Seattle Children's, with participating members Children's National Health System, BC Children's Hospital and Children's Hospital Los Angeles, has launched CureWorks, an international collaborative of leading academic children's hospitals determined to accelerate the development of immunotherapy treatments for childhood cancer.

12 Jun 2018

Tradeshow Talks with Porvair Sciences

We will be featuring our latest automation-ready nitrogen blowdown evaporator, the Ultravap Mistral and our new electronic cap mat applicators at ACHEMA 2018.

From Porvair Sciences Limited 11 Jun 2018

Translate Bio collaborates with Sanofi to develop mRNA vaccines for infectious diseases

Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to develop mRNA vaccines for up to five undisclosed infectious disease pathogens.

11 Jun 2018

EMA grants PRIME designation to Themis' chikungunya vaccine candidate

Themis announced today that the European Medicines Agency has granted PRIority MEdicines designation to its most advanced program in development, a vaccine to prevent chikungunya fever.